- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00803751
A Comparison of the Infant Truview EVO2 Video Laryngoscope and the Macintosh Laryngoscope in Pediatric Patients (Truview)
May 3, 2017 updated by: Maria Matuszczak, The University of Texas Health Science Center, Houston
This study is intended to examine the effectiveness of a new type of laryngoscope, the Truview EVO2, in an infant patient population.
They device will be tested against the current clinical standard, the Macintosh laryngoscope, in patients undergoing surgery at our hospital in terms of ease of use, view obtained of the vocal cords, and ability to place an endotracheal tube.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Memorial Hermann Hospital - Texas Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age less than one year
- Requiring general anesthesia and orotracheal intubation
- Weight less than 10 kg
- ASA class 1-3
Exclusion Criteria:
- Documented difficult airway
- Facial deformities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Truview intubation
Receive laryngoscopy with Truview first and is immediately followed by laryngoscopy and intubation with Macintosh
|
will use the Truview laryngoscope instead of the traditional Macintosh laryngoscope
|
|
Active Comparator: Macintosh intubation
Macintosh blade will be used first followed by laryngoscopy and intubation with the truview
|
Intubation using the traditional Macintosh laryngoscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Laryngeal View Obtained on Comarck Lehane Classification
Time Frame: during laryngoscopy prior to intubation. Few minutes before intubation
|
The view obtained when we do laryngoscopy.
The Comarck Lehane classification is as follows: 1) Most of the glottis is seen; 2a) Only the posterior part of the glottis is visible; 2b) The epiglottis is visible, but none of the glottis can be seen; 3) Not even the epiglottis is visible.
|
during laryngoscopy prior to intubation. Few minutes before intubation
|
|
Number of Intubation Attempts
Time Frame: during intubation prior to surgery
|
Number of participants with the indicated number of intubation attempts (1/2/3)
|
during intubation prior to surgery
|
|
Quality of Laryngeal View Obtained With 2nd Laryngoscopy
Time Frame: during laryngoscopy prior to intubation (few minutes prior to intubation)
|
The view obtained when we do laryngoscopy.
The Comarck Lehane classification is as follows: 1) Most of the glottis is seen; 2a) Only the posterior part of the glottis is visible; 2b) The epiglottis is visible, but none of the glottis can be seen; 3) Not even the epiglottis is visible.
|
during laryngoscopy prior to intubation (few minutes prior to intubation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time Taken for Intubation
Time Frame: throughout the intubation procedure
|
throughout the intubation procedure
|
|
|
POGO Score With 1st Laryngoscopy
Time Frame: Before patient is intubated (few minutes before intubation)
|
POGO score is the percent of glottic opening observed during laryngoscopy.
100% POGO score indicates a full view of glottic opening and 0% POGO score indicates no glottic opening.
|
Before patient is intubated (few minutes before intubation)
|
|
POGO Score With 2nd Laryngoscopy
Time Frame: Before patient is intubated
|
POGO score is the percent of glottic opening observed during laryngoscopy.
100% POGO score indicates a full view of glottic opening and 0% POGO score indicates no glottic opening.
|
Before patient is intubated
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Maria Matuszczak, MD, The University of Texas Health Science Center, Houston
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2008
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
December 5, 2008
First Submitted That Met QC Criteria
December 5, 2008
First Posted (Estimate)
December 8, 2008
Study Record Updates
Last Update Posted (Actual)
May 15, 2017
Last Update Submitted That Met QC Criteria
May 3, 2017
Last Verified
March 1, 2011
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Infant Truview
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.